ÂÜÀòÂÒÂ×

Prof. Dr. Michael Rossbach is a seasoned scientist with expertise in immunology, cell-based therapeutics, neuroscience, and genomics. He is Managing Partner of Ikxinta, a life sciences advisory firm, and holds numerous academic appointments around the world: National University of Singapore, Technical University of Munich in Singapore, INSEAD Management School (Entrepreneur-in-Residence), and Witten School of Management (Germany, Member of Faculty). Dr. Rossbach is an elected member of the Scientific Council of the Deutsches Elektronen-Synchrotron DESY, a research center of the Helmholtz Association.

Dr. Rossbach’s other professional experience includes Vela Diagnostics (clinical and molecular diagnostics to advance precision medicine), Genome Institute of Singapore, and Institute of Reconstructive Neurobiology and LIFE&BRAIN, University of Bonn (Germany). Additionally, he is an Associate with the Biotech Developpement Conseils (France), Partner of the Höppner Life Sciences Management Group (Germany), Partner of the healthcare team of The Center For Innovation Commercialization ( USA), and Venture Partner of Graybella Capital (USA) and A9C Capital (Bahrain). Dr. Rossbach serves on Scientific Advisory Boards of several biotech companies.

Dr. Rossbach studied biochemistry (PhD in immunology) at University of Bonn (Germany), University of New South Wales (Australia), University of Witten/Herdecke (Germany), Max-Planck Institute for molecular Physiology (Germany), and Harvard Medical School (USA).

His scientific interest lies in tumor-immunology, complex gene regulation (particularly in non-coding RNAs), and in stem cell / regenerative biology.